AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Myriad Genetics (myriad.com)
Myriad Genetics presents a professional but clinically vague facade that relies heavily on industry buzzwords to mask a lack of immediate, verifiable evidence. While the medical categories are legitimate, the distance between the ‘life-changing’ marketing and the accessible scientific proof is wider than expected for a leading biotech firm.
Replace fluff-heavy H2s like ‘Powerful tests to illuminate life-changing insights’ with data-specific headers such as ‘Clinically Validated Tests for 5+ Therapeutic Areas.’ Integrate specific regulatory clearance numbers (FDA 510k) and ISO certifications directly into the page metadata and schema. Add Person schema for leading scientific advisors or clinical directors to bridge the authority gap. Explicitly link ‘Accurate’ and ‘Affordable’ claims to a transparent methodology or pricing page.
The site exhibits a moderate information density where substantive clinical categories (Oncology, Urology, Mental Health) are balanced by high-fluff headings. Power words such as ‘Life Changing,’ ‘Powerful,’ and ‘Illuminating’ appear frequently without immediate quantification; for example, the H2 ‘Powerful tests to illuminate life-changing insights’ contains zero specific nouns or metrics. While the heading hierarchy lists specific medical sub-fields, the lack of immediate technical specifications or data-backed claims in the top-level headers creates a high signal-to-noise ratio.
If your content is buried under div based wrappers, AI will treat it as noise instead of meaning. Check your Machine Readability Index with a free one page structural interpretation.
There is very little semantic drift between the homepage and sub-pages; the core promise of ‘Life Changing Insights’ on the homepage is consistently supported by the specialized oncology and provider pages. The transition from the broad hero claim to the specific patient and provider paths is logical and maintains thematic integrity. However, some minor drift occurs in the repetitive use of generic calls-to-action like ‘I’d like to…’ and ‘How can we help you?’ which offer no unique value beyond basic navigation.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site displays a trust-theatre deficit, with review counts of 2-3 per page but only a single proof link across the primary analyzed pages. Claims such as ‘Accurate,’ ‘Affordable,’ and ‘Actionable’ (found in H4 tags on the oncology patient page) are presented as pillars of trust but lack direct, linked citations or third-party validation in the provided data. The ‘Latest studies & publications’ header suggests the existence of proof, but the proof_links_count of 1 indicates a failure to provide direct access to this evidence.
The proof density is low, with a 1:1 ratio of verifiable proof links to general pages, despite the clinical nature of the product which demands a much higher evidence-to-claim ratio. While the site references ‘Latest studies & publications,’ these are not integrated as verifiable proof paths within the primary navigation or page metadata. Most H2 and H3 headings focus on intent and marketing rather than specific outcome data or peer-reviewed citations.
For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.
Myriad Genetics utilizes several industry cliches including ‘transforming patient care’ and ‘paving the way,’ which are noted in the industry pattern dictionary as generic claims. The value proposition of ‘better health through genetic insights’ is a standard commodity statement for the biotech sector and could be easily transposed onto competitors like Invitae or Natera. The template structure is evident in the repetitive ‘Locations’ and ‘Documents & forms’ sections across all sub-pages.
While the company establishes authority through its broad portfolio of tests, there is a notable absence of named medical or scientific experts within the headings or schema data. The schema_json is limited to generic WebPage and WebSite types, failing to utilize MedicalOrganization or Physician schema that would link the brand to verifiable professional entities or key opinion leaders. This creates a technical credibility gap where the ‘authority’ is the brand itself rather than its scientific staff.
The site makes bold performance claims through descriptors like ‘unmatched customer support’ and ‘seamless efficiency’ (H3 tags on the provider page) without providing supporting metrics or case studies. The disconnect between these superlatives and the lack of specific data points (e.g., turnaround times, accuracy percentages) in the visible headers results in a marketing-heavy tone. The reliance on adjectives over data is a primary driver of the score.
Medical Devices, Pharma & Biotech BS: Myriad Genetics (myriad.com)
The website perfectly aligns with the Medical Devices, Pharma & Biotech category, specifically focusing on genomic and genetic testing services. The content emphasizes clinical areas such as oncology, urology, and mental health, utilizing industry-standard terminology like germline and tumor genomic testing.
AI retrieval begins with one question: "What is this page?" Read the Structured Data Technical Guide to learn how correct entity typing and persistent identifiers prevent your site from collapsing into noise.
“The score of 42 is primarily driven by Trust and Proof gaps (11 points) and Identity/Authority issues (9 points). The lack of specific medical schema and the presence of unverified performance claims ('unmatched,' 'accurate') without direct proof links prevent the site from achieving a high-substance rating. Information Density also suffered due to the high ratio of power words in primary headers.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 24, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Myriad Genetics to view the most current version of their content and see directly what the company offers.